Research Summary: Depressive symptoms are common in older adults and have been associated with risk of Alzheimer’s disease and Alzheimer’s disease and related dementias (AD/ADRD), but the mechanisms and biomarkers
Rising mortality related to early-onset Alzheimer’s disease in the United States: trends and disparities, 2003–2023. This retrospective population-based study used Centers for Disease Control (CDC) and Prevention WONDER data to
Neuroplasticity and Alzheimer’s disease Gashtrodkhani AA, Shirkouhi SG, Khatami SS, et al. J Integr Neurosci. 2026;25(1):48051. Summary. In a narrative review of literature investigating neuroplasticity related to Alzheimer’s disease, researchers
Reprinted with permission. J Geriatr Psychiatry Neurol. 2026;39(3):277–287.* by Rebeca Leon, MSc; Maryam Ghahremani, PhD; Dylan X. Guan, BSc; Eric E. Smith, MD; Henrik Zetterberg, MD; and Zahinoor Ismail, MD
Upcoming educational events and digital resources related to Alzheimer’s disease Alzheimer’s Association International Conference 2026 July 12–15, 2026 London, United Kingdom * https://aaic.alz.org/ Autoimmune Neurology Conference August 7–8, 2026
Dr. Irene Malaty, from the University of Florida, discusses how to identify patients who may benefit from Vyalev (foscarbidopa/foslevodopa), highlighting key indicators that a patient is ready to transition beyond
